Antihyperuricemic Lignans from the Leaves of Phyllanthus niruri

Abstract

The methanol extract from the leaves of Phyllanthus niruri L. showed oral antihyperuricemic activity in potassium oxonate- and uric acid-induced hyperuricemic rats. Fractionation of the extract by resin chromatography led to the isolation of a less polar fraction which exhibited the highest reduction of plasma uric acid. Further antihyperuricemic-guided purification of the fraction afforded three lignans, phyllanthin (1), hypophyllanthin (2) and phyltetralin (3), of which 1 significantly reversed the plasma uric acid level of hyperuricemic animals to its normal level in a dose-dependent manner, comparable to that of allopurinol, benzbromarone and probenecid which are used clinically for the treatment of hyperuricemia and gout. Thus, the lignans of P. niruri are potential antihyperuricemic agents worthy of further investigation.

Key words

Phyllanthus niruri L. - Euphorbiaceae - lignans - antihyperuricemic activity - hyperuricemic rats - plasma uric acid analysis

References

• 1 Ghei M, Mihailescu M, Levinson D. Pathogenesis of hyperuricemia: Recent advances.  Curr Rheumatol Rep. 2002;  4 270-4
• 2 Mazzali M, Hughes J, Kim Y G, Jefferson A, Kang D H, Gordon K L. et al . Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.  Hypertension. 2001;  38 1101-6
• 3 Zhu J X, Wang Y, Kong L D, Yang C, Zhang X. Effects of Biota orientalis extract and its flavonoid constituents, quercetin and rutin on serum uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.  J Ethnopharmacol. 2004;  93 133-40
• 4 Dincer H E, Dincer A P, Levinson D J. Asymptomatic hyperuricemia: To treat or not to treat.  Cleveland Clin J Med. 2002;  69 594-608
• 5 Khoo B P, Leow Y H. A review of inpatients with adverse drug reactions to allopurinol.  Singapore Med J. 2000;  41 156-60
• 6 Adel G. Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient.  Curr Rheumatol Rep. 2001;  3 29-35
• 7 Perez-Ruiz F, Alonso-Ruiz A, Calabozo M, Herrero-Beites A, Garcia-Erauskin G, Ruiz-Lucea E. Efficacy of allopurinol and benzbromarone for the control of hyperuricemia. A pathogenic approach to the treatment of primary chronic gout.  Ann Rheum Dis. 1998;  57 545-9
• 8 Owen P L, Johns T. Xanthine oxidase inhibitory activity of northeastern North American plant remedies used for gout.  J Ethnopharmacol. 1999;  64 149-60
• 9 Kong L D, Cai Y, Huang W W, Cheng C HK, Tan R X. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout.  J Ethnopharmacol. 2000;  73 199-207
• 10 Nguyen M TT, Awale S, Tezuka Y, Tran Q L, Watanabe H, Kadota S. Xanthine oxidase Inhibitory activity of Vietnamese Medicinal Plants.  Biol Pharm Bull. 2004;  27 1414-21
• 11 Jalil J, Jantan I, Husain K, Jamal J A, Salleh M S. Tumbuhan ubatan untuk merawat reumatisme. In: Rahmani M, Mahmood M, Sukari MA, Lian GEC, Hin TYY, Ali DAI, editors Proceedings of the 16th National Seminar of Natural Products. Malaysia; Universiti Putra Malaysia 2000: p 146-52
• 12 Kong L D, Yang C, Ge F, Wang H D, Guo Y S. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice.  J Ethnopharmacol. 2004;  93 325-30
• 13 Kong L D, Zhou J, Wen Y, Li J, Cheng C HK. Aesculin possess potent hypouricemic action in rodents but is devoid of xanthine oxidase/dehydrogenase inhibitory activity.  Planta Med. 2002;  68 175-8
• 14 Ding Z, Dai Y, Wang Z. Hypouricemic action of scopoletin arising from xanthine oxidase inhibition and uricosuric activity.  Planta Med. 2005;  71 183-5
• 15 Murugaiyah V, Chan K L. Screening for in vivo antihyperuricemic activity in several Malaysian plants. J Ethnopharmacol, in press
• 16 Unader D W, Webster G L, Blumberg B S. Uses and bioassays in Phyllanthus (Euphorbiaceae): a compilation II. The subgenus Phyllanthus .  J Ethnopharmacol. 1991;  34 97-133
• 17 Somanabandhu A, Nitayangkura S, Mahindol C, Ruchirawat S, Likhitwitayawuid K, Shieh H -L. et al . ¹H- and ¹³C-NMR assignments of phyllanthin and hypophyllanthin: Lignans that enhance cytotoxic responses with cultured multidrug-resistant cells.  J Nat Prod. 1993;  56 233-9
• 18 Anjaneyulu A SR, Rao K J, Row L R, Subrahmanyam C. Crystalline constituents of Euphorbiaceae - XII: Isolation and structural elucidation of three new lignans from the leaves of Phyllanthus niruri Linn.  Tetrahedron. 1973;  29 1291-8
• 19 Ward R S, Satyanarayana P, Row L R, Rao B VG. The case of revised structure for hypophyllanthin - An analysis of the 13 NMR spectra of aryltetralins.  Tetrahedron Lett. 1979;  32 3046
• 20 Satyanarayana P, Venkateswarlu S, Viswanathan K N. Oxidative aryl-aryl, aryl-benzyl coupling of lignans-reactions of phyllanthin and haloderivatives with TTFA, DDQ, Li/THF: Synthesis of dibenzocyclooctadiene system and phyltetralin.  Tetrahedron. 1991;  38 8277-84
• 21 Yamada H, Kotaki H, Furitsu H, Sawada Y, Iga T. Mechanism of the uricosuric action of the anti-inflammatory drug E3040 used to treat inflammatory bowel disease I: Study using a rat model of hyperuricemia.  Biopharm Drug Dispos. 1999;  20 77-83
• 22 Yonetani Y, Iwaki K. Effects of uricosuric drugs and diuretics on uric acid excretion in oxonate-treated rats.  Japan J Pharmacol. 1983;  33 947-54
• 23 Hollinger M A. CRC Handbook of Toxicology. New York; CRC Press 1995: p 783
• 24 Di Carlo G, Autore G, Izzo A A, Maiolino P, Mascolo N, Viola P. et al . Inhibition of intestinal motility and secretion by flavonoids in mice and rats: structure-activity relationships.  J Pharm Pharmacol. 1993;  45 1054-9